» Articles » PMID: 23354587

Survival and Post-warming in Vitro Competence of Human Oocytes After High Security Closed System Vitrification

Overview
Publisher Springer
Date 2013 Jan 29
PMID 23354587
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare two vitrification methods and two warming methods for human oocyte vitrification using a high security closed device in terms of survival, fertilization and embryo development.

Methods: For vitrification, oocytes were (1) immediately placed in equilibration solution or (2) they were gradually exposed to the cryoprotectants. For warming, oocytes were placed (1) in a 25 μl preheated (37 °C) thawing solution droplet that was put at room temperature for 1 min once the oocytes were inside or (2) in a 150 μl droplet for 1 minute at 37 °C.

Results: Survival and preimplantation development were significantly lower when warming was performed in a small preheated droplet. There was no significant difference in survival and embryo development between the gradual or direct exposure to cryoprotectants.

Conclusions: Using this high security closed vitrification device a 90 % survival rate can be achieved when the oocytes are immediately warmed in a large volume at 37 °C.

Citing Articles

Duration of cryostorage is not associated with rates of thaw survival, fertilization, blastulation and ploidy, or pregnancy outcomes of vitrified human oocytes.

Roger S, Estevez S, Hernandez-Nieto C, Kripalani S, Ghofranian A, Baird M J Assist Reprod Genet. 2025; 42(2):525-532.

PMID: 39753943 PMC: 11871184. DOI: 10.1007/s10815-024-03350-z.


The new ice age: the promise and challenges of rapid oocyte warming protocols.

Bartolacci A, Albertini D J Assist Reprod Genet. 2024; 41(11):2969-2971.

PMID: 39556268 PMC: 11621260. DOI: 10.1007/s10815-024-03315-2.


Reply: Concerns regarding the study "Comparing the effects of a commercial and a prototype vitrification medium on meiotic spindle morphology and survival rate of mouse oocytes".

Viana I, Vireque A, Navarro P JBRA Assist Reprod. 2023; 27(3):582-583.

PMID: 37579269 PMC: 10712826. DOI: 10.5935/1518-0557.20230016.


The effect of repeated cryopreservation and thawing using cryotip on the clinical outcomes of embryos.

Mizobe Y, Kuwatsuru Y, Kuroki Y, Fukumoto Y, Tokudome M, Moewaki H Reprod Med Biol. 2021; 20(2):176-181.

PMID: 33850450 PMC: 8022090. DOI: 10.1002/rmb2.12365.


High-security closed devices are efficient and safe to protect human oocytes from potential risk of viral contamination during vitrification and storage especially in the COVID-19 pandemic.

Porcu E, Tranquillo M, Notarangelo L, Ciotti P, Calza N, Zuffa S J Assist Reprod Genet. 2021; 38(3):681-688.

PMID: 33432422 PMC: 7799863. DOI: 10.1007/s10815-021-02062-y.


References
1.
Noyes N, Knopman J, Labella P, McCaffrey C, Clark-Williams M, Grifo J . Oocyte cryopreservation outcomes including pre-cryopreservation and post-thaw meiotic spindle evaluation following slow cooling and vitrification of human oocytes. Fertil Steril. 2010; 94(6):2078-82. DOI: 10.1016/j.fertnstert.2010.01.019. View

2.
Katayama K, Stehlik J, Kuwayama M, Kato O, Stehlik E . High survival rate of vitrified human oocytes results in clinical pregnancy. Fertil Steril. 2003; 80(1):223-4. DOI: 10.1016/s0015-0282(03)00551-x. View

3.
Cobo A, Vajta G, Remohi J . Vitrification of human mature oocytes in clinical practice. Reprod Biomed Online. 2009; 19 Suppl 4:4385. View

4.
Stoop D, Nekkebroeck J, Devroey P . A survey on the intentions and attitudes towards oocyte cryopreservation for non-medical reasons among women of reproductive age. Hum Reprod. 2011; 26(3):655-61. DOI: 10.1093/humrep/deq367. View

5.
Van Landuyt L, De Vos A, Joris H, Verheyen G, Devroey P, Van Steirteghem A . Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization procedure. Fertil Steril. 2005; 83(5):1397-403. DOI: 10.1016/j.fertnstert.2004.10.054. View